203 related articles for article (PubMed ID: 15551883)
1. [Role of Langerhans cells in the immunity of leishmaniasis].
Zuluaga M; Robledo SM
Biomedica; 2004 Sep; 24(3):302-17. PubMed ID: 15551883
[TBL] [Abstract][Full Text] [Related]
2. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.
Moll H
Behring Inst Mitt; 1997 Mar; (99):73-8. PubMed ID: 9303204
[TBL] [Abstract][Full Text] [Related]
3. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.
Silveira FT; Lainson R; Gomes CM; Laurenti MD; Corbett CE
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1075-80. PubMed ID: 18602127
[TBL] [Abstract][Full Text] [Related]
4. The immunology of Leishmania infection and the implications for vaccine development.
Vanloubbeeck Y; Jones DE
Ann N Y Acad Sci; 2004 Oct; 1026():267-72. PubMed ID: 15604504
[TBL] [Abstract][Full Text] [Related]
5. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells.
Peters N; Sacks D
Immunol Rev; 2006 Oct; 213():159-79. PubMed ID: 16972903
[TBL] [Abstract][Full Text] [Related]
6. American tegumentary leishmaniasis: a quantitative analysis of Langerhans cells presents important differences between L. (L.) amazonensis and Viannia subgenus.
Xavier MB; Silveira FT; Demachki S; Ferreira MM; do Nascimento JL
Acta Trop; 2005 Jul; 95(1):67-73. PubMed ID: 15935321
[TBL] [Abstract][Full Text] [Related]
7. Changing views on Langerhans cell functions in leishmaniasis.
Moreno J
Trends Parasitol; 2007 Mar; 23(3):86-8. PubMed ID: 17229590
[TBL] [Abstract][Full Text] [Related]
8. [Immunopathogenesis of Leishmania infections].
Yurdakul P
Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
[TBL] [Abstract][Full Text] [Related]
10. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis.
Moll H
Immunol Today; 1993 Aug; 14(8):383-7. PubMed ID: 8397776
[TBL] [Abstract][Full Text] [Related]
11. Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis.
Weiss R; Scheiblhofer S; Thalhamer J; Bickert T; Richardt U; Fleischer B; Ritter U
Vaccine; 2007 Jan; 25(1):25-33. PubMed ID: 17064826
[TBL] [Abstract][Full Text] [Related]
12. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
13. Immune response to leishmania: paradox rather than paradigm.
Tripathi P; Singh V; Naik S
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):229-42. PubMed ID: 17714488
[TBL] [Abstract][Full Text] [Related]
14. Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts.
Antoine JC; Prina E; Courret N; Lang T
Adv Parasitol; 2004; 58():1-68. PubMed ID: 15603761
[TBL] [Abstract][Full Text] [Related]
15. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
16. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression.
Akuffo HO; Fehniger TE; Britton S
J Immunol; 1988 Oct; 141(7):2461-6. PubMed ID: 3171177
[TBL] [Abstract][Full Text] [Related]
17. [Current data on epidermal Langerhans cells].
Dezutter-Dambuyant C
Pathol Biol (Paris); 1994 Oct; 42(8):767-74. PubMed ID: 7724248
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
19. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
[TBL] [Abstract][Full Text] [Related]
20. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
